In Vitro–In Vivo Correlations of Scalable PLGA-Risperidone Implants for the Treatment of Schizophrenia

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pharmaceutical Research

• Publication date

  2010-04-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11095-010-0152-4PMID 20422263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia

  2009influential reference
• Pharmacology and Therapeutics: Principles to Practice

  2008cited by this paper
• In vitro and in vivo demonstration of risperidone implants in mice.

  2008influential reference
• Effects of risperidone on dopamine receptor subtypes in developing rat brain.

  2007cited by this paper
• The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.

  2007cited by this paper
• Profiling in vitro drug release from subcutaneous implants: a review of current status and potential implications on drug product development

  2006cited by this paper
• Effect of drug type on the degradation rate of PLGA matrices.

  2006cited by this paper
• Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat.

  2006cited by this paper
• Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits

  2006cited by this paper
• Utilization of Long-Acting Antipsychotic Medication in Patient Care

  2006cited by this paper
• Severe liver enzyme elevations after three years of olanzapine treatment: a case report and review of olanzapine associated hepatotoxicity.

  2006cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• The economic burden of schizophrenia in the United States in 2002.

  2005influential reference
• Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients.

  2005cited by this paper
• Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.

  2004cited by this paper
• The Mean Dissolution Time Depends on the Dose/Solubility Ratio

  2003cited by this paper
• HGF, MET, and Matrix-Related Proteases in Hepatocellular Carcinoma, Fibrolamellar Variant, Cirrhotic and Normal Liver

  2003cited by this paper
• A meta-analysis of the efficacy of second-generation antipsychotics.

  2003cited by this paper
• Relapse and rehospitalization: comparing oral and depot antipsychotics.

  2003cited by this paper
• Surgically Implantable Long-term Antipsychotic Delivery Systems for the Treatment of Schizophrenia

  2002influential reference
• Minimization of initial burst in poly(vinyl alcohol) hydrogels by surface extraction and surface-preferential crosslinking.

  2002cited by this paper
• Hospitalization and Total Medical Costs for Privately Insured Persons with Schizophrenia

  2001cited by this paper
• Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.

  2001cited by this paper
• On the importance and mechanisms of burst release in matrix-controlled drug delivery systems.

  2001cited by this paper
• Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

  2000cited by this paper
• Atypical Antipsychotics: Part II Adverse Effects, Drug Interactions, and Costs

  1999cited by this paper
• Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

  1999cited by this paper
• The economic impact of schizophrenia.

  1999cited by this paper
• Risperidone-induced Hepatotoxicity

  1998cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• Biodegradable microspheres in drug delivery.

  1995cited by this paper
• Risperidone in the treatment of schizophrenia.

  1994cited by this paper
• Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.

  1990cited by this paper
• In vivo and in vitro degradation of glycine/DL-lactic acid copolymers.

  1989cited by this paper
• Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

  1988cited by this paper
• Changing from oral to depot fluphenazine.

  1988cited by this paper
• Changing from oral to depot fluphenazine.

  1988cited by this paper
• Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems.

  1985cited by this paper
• Development of drug delivery systems for use in treatment of narcotic addiction.

  1981cited by this paper
• THE UNITED STATES PHARMACOPEIA.

  1908cited by this paper

• PLGA-based long-acting injectable (LAI) formulations.

  2025cites this paper
• Recent advances in PLGA-based resorbable implants for biomedical applications

  2025cites this paper
• Anticancer effects of 6-diazo-5-oxo-L-norleucine (DON)-loaded PLGA nanoparticles in triple-negative breast cancer by inhibiting glutamine metabolism: An integrated bioinformatic and experimental approach

  2025cites this paper
• Molecular and Macroscopic Considerations for Degradable Aliphatic Polyester Biomaterial Design.

  2025cites this paper
• Assessing the impact of cryoprotectants on the viability and characteristics of chlorthalidone loaded nanocrystals for enhancing the dissolution rate and bioavailability

  2025cites this paper
• Development of Stabilized and Aqueous Dissolvable Nanosuspension Encompassing BCS Class IV Drug via Optimization of Process and Formulation Variables.

  2025cites this paper
• Size-Exclusion Chromatography–Electrospray-Ionization Mass Spectrometry To Characterize End Group and Chemical Distribution of Poly(lactide-co-glycolide) Copolymers

  2025cites this paper
• Novel microdialysis method for complex generic products

  2025cites this paper
• Hyaluronic acid oligosaccharides promote micro-vessel growth and regenerative ossification in biomimetic calvarial bone scaffolds.

  2025cites this paper
• PLGA Implants for Controlled Drug Delivery and Regenerative Medicine: Advances, Challenges, and Clinical Potential

  2025cites this paper
• Quality-by-Design Based Development of Doxycycline Hyclate–Loaded Polymeric Microspheres for Prolonged Drug Release

  2024cites this paper
• SAHA potentiates the activity of repurposed drug promethazine loaded PLGA nanoparticles in triple-negative breast cancer cells

  2024cites this paper
• Development and Applications of PLGA Hydrogels for Sustained Delivery of Therapeutic Agents

  2024cites this paper
• 3D Bioprinting of Artificial Skin Substitute with Improved Mechanical Property and Regulated Cell Behavior through Integrating Patterned Nanofibrous Films.

  2024cites this paper
• In vivo research on 3D-printed composite PLGA and PDLLA-HA absorbable scaffolds for repairing radius defects in rabbits

  2024cites this paper
• Optimization of Lurasidone HCl-Loaded PLGA Nanoparticles for Intramuscular Delivery: Enhanced Bioavailability, Reduced Dosing Frequency, Pharmacokinetics, and Therapeutic Outcomes

  2023cites this paper
• Application of a Customised Franz-Type Cell Coupled with HPTLC to Monitor the Timed Release of Bioactive Components in Complex Honey Matrices

  2023cites this paper
• The Impact of Post-Processing Temperature on PLGA Microparticle Properties

  2023cites this paper
• Therapeutic Targeting of Lung Adenocarcinoma with Mannose-Coated Chitosan/Copper Nanocluster–Levocetirizine Nanocomposite

  2023cites this paper
• Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research

  2023cites this paper
• Latest research about active pharmaceutical ingredient loaded Poly Lactic Acid-co-Glycolic Acid (PLGA) based drug delivery system in Türkiye

  2023cites this paper
• CaMKIIα heterozygous knockout mice show EEG and behavioral changes characteristic of a subpopulation of schizophrenia and intellectual impairment.

  2022cites this paper
• Microfluidic Particle Reactors: From Interface Characteristics to Cells and Drugs Related Biomedical Applications

  2022cites this paper
• Correlative Image-Based Release Prediction and 3D Microstructure Characterization for a Long Acting Parenteral Implant

  2021cites this paper
• Biomaterials for protein delivery for complex tissue healing responses.

  2021cites this paper
• Formulation of stabilizer-free, nontoxic PLGA and elastin-PLGA nanoparticle delivery systems.

  2021cites this paper
• Polymeric implants with drug-releasing capabilities: a mapping review of laboratory research

  2021cites this paper
• PLGA-based drug delivery system for combined therapy of cancer: research progress

  2021cites this paper
• Release mechanisms and practical percolation threshold for long-acting biodegradable implants: An image to simulation study.

  2021cites this paper
• Antioxidant Effects of the Prenylated Flavonoid, Xanthohumol, on Corneal Epithelial Cells in Experimental Dry Eye Disease

  2021cites this paper
• Nanopharmacokinetics assessment

  2021cites this paper
• Hollow mesoporous silica nanoparticles for co-delivery of hydrophobic and hydrophilic molecules: mechanism of drug loading and release

  2021cites this paper
• Poly(lactic-co-glycolic acid) Nanoparticles Encapsulating the Prenylated Flavonoid, Xanthohumol, Protect Corneal Epithelial Cells from Dry Eye Disease-Associated Oxidative Stress

  2021cites this paper
• Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles

  2021cites this paper
• Potential of star-shaped polymeric nanoparticles of poly(ε-carprolactone) and poly (lactic-co-glycolic acid) for drug delivery; A comparative study with linear analogs

  2021cites this paper
• Coupling the in vivo performance to the in vitro characterization of PLGA microparticles.

  2021cites this paper
• The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

  2021cites this paper
• Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats

  2020cites this paper
• Drug-Eluting Biodegradable Implants for the Sustained Release of Bisphosphonates

  2020cites this paper
• Pharmaceutical implants: classification, limitations and therapeutic applications

  2020cites this paper
• Biodegradable Poly (lactic-co-glycolic acid) Microparticles Controlled Delivery System: A Review

  2020cites this paper
• Lancing Drug Reservoirs into Subcutaneous Fat to Combat Obesity and Associated Metabolic Diseases.

  2020cites this paper
• Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticles.

  2020cites this paper
• Optimization of injectable PLGA in-situ forming implants of anti-psychotic risperidone via Box-Behnken Design

  2020cites this paper
• Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis

  2019cites this paper
• by Submitted in partial satisfaction of the requirements for degree of in in the GRADUATE DIVISION of the UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

  2019cites this paper
• Nuclear Magnetic Resonance (NMR) Applications in Nanoparticles: Dynamic Nuclear Polarization and Nanoparticle Surface Interaction

  2019cites this paper
• Vancomycin- and Poly(simvastatin)-Loaded Scaffolds with Time-Dependent Development of Porosity.

  2019cites this paper
• Injectables

  2019cites this paper
• Exploration of long-acting implant formulations of hepatitis B drug entecavir.

  2019cites this paper
• Butyl stearate prolongs the drug release period of isoperidone-loaded poly (lactic-co-glycolic acid) microspheres: In vitro and in vivo investigation

  2018cites this paper
• Customizing poly(lactic-co-glycolic acid) particles for biomedical applications.

  2018cites this paper
• Self-assembled micelles prepared from poly(ɛ-caprolactone)-poly(ethylene glycol) and poly(ɛ-caprolactone/glycolide)-poly(ethylene glycol) block copolymers for sustained drug delivery

  2018cites this paper
• Drug release and biocompatibility of self-assembled micelles prepared from poly (ɛ-caprolactone/glycolide)-poly (ethylene glycol) block copolymers

  2018cites this paper
• Optimization of rhein-loaded polymeric nanoparticles using a factorial design and evaluation of the cytotoxic and anti-inflammatory effects

  2018cites this paper
• Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications

  2018cites this paper
• Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia

  2018cites this paper
• A bilayered PVA/PLGA-bioresorbable shuttle to improve the implantation of flexible neural probes

  2018cites this paper
• Biodegradable bead-on-spring nanofibers releasing β-carotene for bone tissue engineering.

  2018cites this paper
• PREPARATION, CHARACTERIZATION AND EVALUATION OF POLY (LACTIDE –CO –GLYCOLIDE) MICROSPHERES FOR THE CONTROLLED RELEASE OF ZIDOVUDINE

  2017cites this paper
• Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?

  2017cites this paper
• 1-22-2014 IVIVC from Long Acting Olanzapine Microspheres

  2017cites this paper
• Encapsulation of Nicardipine Hydrochloride and Release from Biodegradable Poly(D,L-lactic-co-glycolic acid) Microparticles by Double Emulsion Process: Effect of Emulsion Stability and Different Parameters on Drug Entrapment

  2017cites this paper
• A method to slow down the ionization-dependent release of risperidone loaded in a thermoresponsive poly(N-acryloyl glycinamide) hydrogel

  2017cites this paper
• Psychotropic implant can be a new hope in psychiatry.

  2017cites this paper
• Effects of physicochemical properties of poly(lactide-co-glycolide) on drug release behavior of hydrophobic drug-loaded nanoparticles

  2017cites this paper
• Drug release behavior of hydrophobic drug-loaded poly (lactide-co-glycolide) nanoparticles: Effects of glass transition temperature

  2017cites this paper
• Bio-relevant characterisation of lipidic formulations and prediction of in vivo exposure

  2017cites this paper
• Comparative pharmacokinetics of PLGA & PCL based long acting injectable (LAI) risperidone microsphere formulations

  2017cites this paper
• PLGA-based nanoparticles: A new paradigm in biomedical applications

  2016cites this paper
• Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme

  2016cites this paper
• Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.

  2016cites this paper
• Enhancing the bioavailability of BCS Class IV drugs using polymeric nanoparticles

  2016cites this paper
• Advanced Implantable Drug Delivery Systems via Continuous Manufacturing.

  2016cites this paper
• PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.

  2016cites this paper
• Study of the interactions of surface-modified particles with membrane model systems

  2016cites this paper
• Development of a novel 3-month drug releasing risperidone microspheres

  2015cites this paper
• Preparation and evaluation of pralidoxime-loaded PLGA nanoparticles as potential carriers of the drug across the blood brain barrier

  2015cites this paper
• Sequential delivery of antibiotics and probiotics employing a dual release mechanism

  2015cites this paper
• In vitro-in vivo correlation for complex non-oral drug products: Where do we stand?

  2015cites this paper
• Poly(lactic-co-glycolic acid) matrix incorporated with nisin as a novel antimicrobial biomaterial

  2015cites this paper
• IN VITRO IN VIVO CORRELATION BASIS AND APPLICATION TO SLOW RELEASE INJECTABLE FORMULATION , A REVIEW

  2015cites this paper
• Current approaches for in vitro drug release study of long acting parenteral formulations.

  2015cites this paper
• Poly(lactic-co-glycolic acid) matrix incorporated with nisin as a novel antimicrobial biomaterial

  2015cites this paper
• Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis

  2015cites this paper
• Development of High Drug Loaded and Customizing Novel Nanoparticles for Modulated and Controlled Release of Paclitaxel

  2014cites this paper
• Animal Models of Psychosis: Current State and Future Directions

  2014cites this paper
• IVIVC from Long Acting Olanzapine Microspheres

  2014cites this paper
• Nanoparticles containing insoluble drug for cancer therapy.

  2014cites this paper
• Novel Model for the Description of the Controlled Release of 5-Fluorouracil from PLGA and PLA Foamed Scaffolds Impregnated in Supercritical CO2

  2014cites this paper
• Validation of a Mathematical Model for the Description of Hydrophilic and Hydrophobic Drug Delivery from Biodegradable Foams: Experimental and Comparison Using Indomethacin as Released Drug

  2014cites this paper
• Acceleration of re-endothelialization and inhibition of neointimal formation using hybrid biodegradable nanofibrous rosuvastatin-loaded stents.

  2014cites this paper
• Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies

  2014cites this paper
• A Review of In Vitro Drug Release Test Methods for Nano-Sized Dosage Forms

  2014cites this paper
• Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery

  2014cites this paper
• In Vitro Characterization of Six Month Dosage Forms for a GnRH Antagonist

  2014cites this paper
• Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning.

  2014cites this paper
• Microparticles produced by the hydrogel template method for sustained drug delivery.

  2014cites this paper
• A bioresponsive polymeric implant for site-specific prolonged drug delivery

  2014cites this paper
• In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms

  2014cites this paper